The Chinese government has announced a new policy to fundamentally reduce marked-up prices and corruption in multi-tier distribution chains. The policy effectively requires, under most circumstances, at most only two
Drug makers face sweeping distribution overhaul
China launches a “Two-Invoice System” to simplify the drug distribution chain and reduce prices and corruption in the healthcare sector. The new policy may bring substantial compliance and business model challenges for pharmaceutical companies
By
Katherine Jo
& clp articles